Clinical Trial Update: Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating platinum-based chemotherapy with Atezolizumab and Niraparib in patients with recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Niraparib (Niraparib)

Snippet

Sponsor: Grupo Español de Investigación en Cáncer de Ovario | Conditions: Recurrent Ovarian Carcinoma | Phase 3 | Status: COMPLETED